| Dr Lauren Renee Smith-leed, MD | |
|
13515 Wolfe Rd Ste D, New Freedom, PA 17349-9346 | |
| (717) 812-2540 | |
| (717) 715-1310 |
| Full Name | Dr Lauren Renee Smith-leed |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 15 Years |
| Location | 13515 Wolfe Rd Ste D, New Freedom, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770725814 | NPI | - | NPPES |
| 2895492 | Other | PA | HIGHMARK BLUE SHIELD |
| 30153379 | Other | PA | AMERIHEALTH CARITAS - WMG |
| 102828670 | Medicaid | PA | |
| 1622548 | Other | PA | GATEWAY |
| 420235 | Other | PA | UPMC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD448388 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| York Hospital | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
Researchers at the University of Calgary, Canada, shed light on how surgical services have been reorganized during and following the COVID-19 pandemic.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today announced an additional randomized, multi-centre Phase III clinical trial for TheraSphere, Nordion's yttrium-90 (Y-90) glass microsphere treatment for liver cancer.
A new report, based on data from the Framingham Heart Study (FHS), suggests that insulin resistance, a predictor of cardiovascular risk and the development of diabetes, may be modulated with even modest levels of physical activity.
Massachusetts General Hospital researchers say they have determined how iron contributes to the production of brain-destroying plaques found in Alzheimer's patients.
› Verified 9 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326060492 PECOS PAC ID: 2961307467 Enrollment ID: O20031205000629 |
News Archive
Researchers at the University of Calgary, Canada, shed light on how surgical services have been reorganized during and following the COVID-19 pandemic.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today announced an additional randomized, multi-centre Phase III clinical trial for TheraSphere, Nordion's yttrium-90 (Y-90) glass microsphere treatment for liver cancer.
A new report, based on data from the Framingham Heart Study (FHS), suggests that insulin resistance, a predictor of cardiovascular risk and the development of diabetes, may be modulated with even modest levels of physical activity.
Massachusetts General Hospital researchers say they have determined how iron contributes to the production of brain-destroying plaques found in Alzheimer's patients.
› Verified 9 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Researchers at the University of Calgary, Canada, shed light on how surgical services have been reorganized during and following the COVID-19 pandemic.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today announced an additional randomized, multi-centre Phase III clinical trial for TheraSphere, Nordion's yttrium-90 (Y-90) glass microsphere treatment for liver cancer.
A new report, based on data from the Framingham Heart Study (FHS), suggests that insulin resistance, a predictor of cardiovascular risk and the development of diabetes, may be modulated with even modest levels of physical activity.
Massachusetts General Hospital researchers say they have determined how iron contributes to the production of brain-destroying plaques found in Alzheimer's patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lauren Renee Smith-leed, MD 601 Memory Ln, York, PA 17402-2231 Ph: (717) 812-2540 | Dr Lauren Renee Smith-leed, MD 13515 Wolfe Rd Ste D, New Freedom, PA 17349-9346 Ph: (717) 812-2540 |
News Archive
Researchers at the University of Calgary, Canada, shed light on how surgical services have been reorganized during and following the COVID-19 pandemic.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today announced an additional randomized, multi-centre Phase III clinical trial for TheraSphere, Nordion's yttrium-90 (Y-90) glass microsphere treatment for liver cancer.
A new report, based on data from the Framingham Heart Study (FHS), suggests that insulin resistance, a predictor of cardiovascular risk and the development of diabetes, may be modulated with even modest levels of physical activity.
Massachusetts General Hospital researchers say they have determined how iron contributes to the production of brain-destroying plaques found in Alzheimer's patients.
› Verified 9 days ago
Dr. Derek Liang, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13515 Wolfe Rd, New Freedom, PA 17349 Phone: 717-812-2540 Fax: 717-715-1310 | |
Dr. Mary O Keperling, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13515 Wolfe Rd, Suite D, New Freedom, PA 17349 Phone: 717-812-2540 Fax: 717-715-1310 |